We have used molecular dynamics simulations to investigate the ordering of top-shaped molecules in bulk phases and in unsupported thin films. Each rigid anisotropic molecule was composed of 11 Lennard-Jones interaction centers (beads). In an attempt to enhance the nematic stability in preference to smectic, the three central beads were assigned a larger Lennard-Jones diameter than the tail beads, giving the molecule a shape resembling a top. The molecular model was found to exhibit an unusual bulk mesophase with long-range orientational order and with molecular center-of-mass positions arranged in parallel interdigitated layers, with layer spacing smaller than half the length of the long axis of a molecule. However, despite the toplike molecular shape, no nematic phase was observed in the pressure range studied. Unsupported films of the isotropic liquid were cooled in order to locate a triple point between the novel mesophase, vapor, and isotropic liquid. At temperatures slightly above the triple point, enhanced surface ordering of molecules was found to occur in the unsupported film. At temperatures slightly below the triple point, the preferred molecular alignment in the unsupported film was parallel to the interface, in violation of arguments that have been proposed based on the relative enthalpies of various cleavage planes for close-packed structures.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1063/1.2180779 | DOI Listing |
Medicina (Kaunas)
December 2024
Department of Medical Oncology, Sanko University Medical Faculty Gaziantep Türkiye, Gaziantep 27090, Türkiye.
: Among breast cancer molecular types, HER2 positive and triple negative (TN) subtypes have the highest likelihood of pathological complete response (pCR), which is a surrogate marker for reduced recurrence and improved patient survival after neoadjuvant systemic treatment (NST). Preoperative pathological identification of these exceptional responders is a new era. Therefore, we aimed to determine the accuracy of trucut biopsy in identifying the exceptional responders in selected molecular subtypes of breast cancer patients.
View Article and Find Full Text PDFDiagnostics (Basel)
January 2025
Department of Medical Oncology, Sivas Cumhuriyet University School of Medicine, Sivas 58140, Turkey.
: This study evaluated the prognostic impact of Trop-2, CD47, and CD163 expression on clinical outcomes in triple-negative breast cancer (TNBC) and investigated their interactions with tumor progression. : A retrospective cohort of 92 patients with TNBC was analyzed. The expression scores for Trop-2, CD47, and CD163 were categorized as negative/low (0-3 points) or high (4-6 points).
View Article and Find Full Text PDFRespir Res
January 2025
Chiesi Farmaceutici, R&D Department, Parma, Italy.
Background: Bronchopulmonary dysplasia (BPD) is a chronic lung condition of premature neonates, yet without an established pharmacological treatment. The BPD rabbit model exposed to 95% oxygen has been used in recent years for drug testing. However, the toxicity of the strong hyperoxic hit precludes a longer-term follow-up due to high mortality after the first week of life.
View Article and Find Full Text PDFIndian Dermatol Online J
December 2024
The Venkat Centre for Advanced Dermatology, Plastic Surgery and ENT, Bengaluru, Karnataka, India.
Background: Trichoscopy is a simple, noninvasive tool to help in the diagnosis of various hair and scalp disorders. There is paucity of data on the normal trichoscopic parameters of hair density and diameter in the Indian population.
Aim: The aim of this study was to establish the trichoscopic patterns of hair and scalp in healthy Indian males and to provide a framework for future reference.
BMC Cancer
January 2025
Department of Breast Surgery, the First Hospital of China Medical University, Shenyang, Liaoning, 110001, China.
Background: Not all breast cancer (BC) patients can benefit from neoadjuvant therapy (NAT). A poor response may result in patients missing the best opportunity for treatment, ultimately leading to a poor prognosis. Thus, to identify an effective predictor that can assess and predict patient response at early time points, we focused on circulating tumor DNA (ctDNA), which is a vital noninvasive liquid biopsy biomarker.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!